These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8800346)
1. The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Pirttilä T; Lehtimäki T; Rinne J; Mattila K; Frey H; Nikkari T Acta Neurol Scand; 1996 May; 93(5):352-4. PubMed ID: 8800346 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Isoe K; Urakami K; Sato K; Takahashi K Acta Neurol Scand; 1996; 93(2-3):133-7. PubMed ID: 8741132 [TBL] [Abstract][Full Text] [Related]
3. Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population. Kálmán J; Juhász A; Császár A; Kanka A; Rimanóczy A; Janka Z; Raskó I Acta Neurol Scand; 1998 Sep; 98(3):166-8. PubMed ID: 9786612 [TBL] [Abstract][Full Text] [Related]
4. [Apolipoprotein E and tau protein in vascular dementia]. Paradowski B; Dobosz T; Sasiadek M; Szczepaniak M Pol Merkur Lekarski; 2003 Jul; 15(85):69-71. PubMed ID: 14593964 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform. Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K Dementia; 1996; 7(5):273-8. PubMed ID: 8872419 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E as vascular risk factor in neurodegenerative dementia. Folin M; Baiguera S; Conconi MT; Di Liddo R; De Carlo E; Parnigotto PP; Nussdorfer GG Int J Mol Med; 2004 Oct; 14(4):609-13. PubMed ID: 15375590 [TBL] [Abstract][Full Text] [Related]
7. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia. Treves TA; Bornstein NM; Chapman J; Klimovitzki S; Verchovsky R; Asherov A; Veshchev IO; Korczyn AD Alzheimer Dis Assoc Disord; 1996; 10(4):189-91. PubMed ID: 8939277 [TBL] [Abstract][Full Text] [Related]
8. The relationship between apolipoprotein E, dementia, and vascular illness. Marin DB; Breuer B; Marin ML; Silverman J; Schmeidler J; Greenberg D; Flynn S; Mare M; Lantz M; Libow L; Neufeld R; Altstiel L; Davis KL; Mohs RC Atherosclerosis; 1998 Sep; 140(1):173-80. PubMed ID: 9733229 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Lehtimäki T; Pirttilä T; Mehta PD; Wisniewski HM; Frey H; Nikkari T Hum Genet; 1995 Jan; 95(1):39-42. PubMed ID: 7814023 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan. Nakayama S; Kuzuhara S Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia. Rodriguez Martin T; Calella AM; Silva S; Munna E; Modena P; Chiesa R; Terrevazzi S; Ruggieri RM; Palermo R; Piccoli F; Confalonieri R; Tiraboschi P; Fragiacomo C; Quadri P; Lucca U; Forloni G Dement Geriatr Cogn Disord; 2000; 11(5):239-44. PubMed ID: 10940674 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 allele frequency in vascular dementia. Davidson Y; Gibbons L; Purandare N; Byrne J; Hardicre J; Wren J; Payton A; Pendleton N; Horan M; Burns A; Mann DM Dement Geriatr Cogn Disord; 2006; 22(1):15-9. PubMed ID: 16645276 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Ji Y; Urakami K; Adachi Y; Maeda M; Isoe K; Nakashima K Dement Geriatr Cogn Disord; 1998; 9(5):243-5. PubMed ID: 9701675 [TBL] [Abstract][Full Text] [Related]
14. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259 [TBL] [Abstract][Full Text] [Related]
15. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls. Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster. Pirttilä T; Haanpää M; Mehta PD; Lehtimäki T Acta Neurol Scand; 2000 Aug; 102(2):94-8. PubMed ID: 10949525 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations. Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T Clin Chem; 1999 Apr; 45(4):497-504. PubMed ID: 10102909 [TBL] [Abstract][Full Text] [Related]
18. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508 [TBL] [Abstract][Full Text] [Related]